MIRO1 has increased expression in tumors compared to adjacent normal tissue in hepatocellular carcinoma (HCC) (30), gastric cancer (31), and pancreatic cancer (PC) (32). This evidence concerns the gene RHOT1 and hepatocellular carcinoma.